Fate Therapeutics (FATE) PT Raised to $8 at Piper Sandler
Piper Sandler analyst Edward Tenthoff ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)